Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Mevalonate kinase-associated inflammatory diseases

Mevalonate kinase-associated inflammatory diseases is a group of disorders caused by mutations of the MVK gene. Depending on the type of mutation, reactions can be local skin leasions or severly systemic.

Classification

According to allelic variants three phenotypes can be distinguished:

  1. Poroceratosis 3 is the mildes form showing only skin lesions. Inheritance is dominant.
  2. Hyper-IgD syndrome is characterized by recurrent fever and elevated immunoglobulin D. Inheritance is recessive.
  3. Mevalonic aciduria is the most severe form involving many organ systems and causing early death. Inheritance is recessive.

Systematic

Systemic autoinflammatory disease
ADA2 deficiency
Cryopyrin-associated periodic syndrome
Mevalonate kinase-associated inflammatory diseases
Hyper-IgD syndrome
MVK
Mevalonic aciduria
MVK
Porokeratosis 3
MVK
NOD2-associated disease
Pyrin-associated autoinflammatory disease

References:

1.

Houten SM et al. (2001) Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome.

external link
2.

Toplak N et al. (2012) An international registry on autoinflammatory diseases: the Eurofever experience.

external link
3.

Shinar Y et al. (2020) ISSAID/EMQN Best Practice Guidelines for the Genetic Diagnosis of Monogenic Autoinflammatory Diseases in the Next-Generation Sequencing Era.

external link
4.

Touitou I et al. (2004) Infevers: an evolving mutation database for auto-inflammatory syndromes.

external link
5.

Gibson KM et al. (1997) Mevalonate kinase map position 12q24.

external link
6.

Hoffmann GF et al. (1993) Clinical and biochemical phenotype in 11 patients with mevalonic aciduria.

external link
7.

Krisans SK et al. (1994) Farnesyl-diphosphate synthase is localized in peroxisomes.

external link
8.

Fredonnet J et al. (2014) Topographical and nano-mechanical characterization of native corneocytes using atomic force microscopy.

external link
9.

Zhang SQ et al. (2012) Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis.

external link
10.

Mandey SH et al. (2006) Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency.

external link
11.

Wu LQ et al. (2004) Confirmation and refinement of a genetic locus for disseminated superficial actinic porokeratosis (DSAP1) at 12q23.2-24.1.

external link
12.

Schafer BL et al. (1992) Molecular cloning of human mevalonate kinase and identification of a missense mutation in the genetic disease mevalonic aciduria.

external link
13.

Drenth JP et al. (1994) Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group.

external link
14.

Hinson DD et al. (1999) Identification of a mutation cluster in mevalonate kinase deficiency, including a new mutation in a patient of Mennonite ancestry.

external link
15.

Houten SM et al. (1999) Identification and characterization of three novel missense mutations in mevalonate kinase cDNA causing mevalonic aciduria, a disorder of isoprene biosynthesis.

external link
16.

van der Meer JW et al. (1984) Hyperimmunoglobulinaemia D and periodic fever: a new syndrome.

external link
17.

Siemiatkowska AM et al. (2013) Mutations in the mevalonate kinase (MVK) gene cause nonsyndromic retinitis pigmentosa.

external link
18.

Balgobind B et al. (2005) Retinitis pigmentosa in mevalonate kinase deficiency.

external link
19.

D'Osualdo A et al. (2005) MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever.

external link
20.

Prietsch V et al. (2003) Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum.

external link
21.

Houten SM et al. (2002) Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome.

external link
22.

Cuisset L et al. (2001) Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome.

external link
23.

Drenth JP et al. (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group.

external link
24.

Houten SM et al. (1999) Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome.

external link
25.

OMIM.ORG article

Omim 251170 external link
Update: Aug. 14, 2020
Copyright © 2005-2024 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits